Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elevance Health (DE:A58)
FRANKFURT:A58
Elevance Health (A58) Stock Price & Analysis
2 Followers
A58 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€366.44 - €503.80
Previous Close€503.8
Volume0.00
Average Volume (3M)17.00
Market Cap
€116.67B
Enterprise Value€120.95B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$4.47B
Price to Earnings (P/E)N/A
Beta-0.06
Next Earnings
Jul 17, 2024EPS Estimate
€9.37Next Dividend Ex-Date
Jun 10, 2024Dividend Yield1.12%
Share Statistics
EPS (TTM)N/A
Shares Outstanding232,417,867
10 Day Avg. Volume3
30 Day Avg. Volume17
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)31.60
Price to Sales (P/S)0.68
Price to Cash Flow (P/CF)15.80
P/FCF Ratio14.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.70
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€566.06Price Target Upside12.36% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering13
Elevance Health News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceElevance Health delivered a strong start to the year with an adjusted EPS exceeding expectations, underpinned by well-contained medical costs and improving profitability in its Health Benefits business.
Growth OutlookElevance Health's raised earnings guidance reflects the company's confidence in its financial performance and its commitment to delivering robust EPS growth over the coming years.
Strategic DevelopmentsThe partnership with Clayton, Dubilier & Rice to expand into primary care and the plan to acquire Kroger’s specialty pharmacy highlight Elevance Health's strategic initiatives to drive future growth.
Bears Say
Membership DeclineTotal membership declined year-over-year, with a particularly sharp decrease in Medicaid membership.
Revenue And Pricing PressureCarelonRx revenue was below estimates, despite an increase in prescriptions, indicating pricing pressure.
Stakeholder ConcernsBCBS LA has again withdrawn its application to be purchased by ELV, indicating difficulties in overcoming stakeholder concerns.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
2.47% Other Institutional Investors
97.53% Public Companies and
Individual Investors
A58 FAQ
What was Elevance Health’s price range in the past 12 months?
Elevance Health lowest stock price was €366.44 and its highest was €503.80 in the past 12 months.
What is Elevance Health’s market cap?
Currently, no data Available
When is Elevance Health’s upcoming earnings report date?
Elevance Health’s upcoming earnings report date is Jul 17, 2024 which is in 79 days.
How were Elevance Health’s earnings last quarter?
Elevance Health released its earnings results on Apr 18, 2024. The company reported €9.937 earnings per share for the quarter, beating the consensus estimate of €9.824 by €0.113.
Is Elevance Health overvalued?
According to Wall Street analysts Elevance Health’s price is currently Undervalued.
Does Elevance Health pay dividends?
Elevance Health pays a Quarterly dividend of €1.52 which represents an annual dividend yield of 1.12%. See more information on Elevance Health dividends here
What is Elevance Health’s EPS estimate?
Elevance Health’s EPS estimate is €9.37.
How many shares outstanding does Elevance Health have?
Currently, no data Available
What happened to Elevance Health’s price movement after its last earnings report?
Elevance Health reported an EPS of €9.937 in its last earnings report, beating expectations of €9.824. Following the earnings report the stock price went up 0.126%.
Which hedge fund is a major shareholder of Elevance Health?
Among the largest hedge funds holding Elevance Health’s share is First Eagle Investment Management LLC. It holds Elevance Health’s shares valued at 839M.
---
Elevance Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€566.06 (12.36% Upside)
€566.06 (12.36% Upside)
Blogger Sentiment
Bullish
DE:A58 Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $12.5M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
20.29%
12-Months-Change
Fundamentals
Return on Equity
16.02%
Trailing 12-Months
Asset Growth
2.62%
Trailing 12-Months
Company Description
Elevance Health
Indiana-based Anthem, Inc. was formed in 2004 after the merger of WellPoint Health Networks Inc. and Anthem, Inc. The company is one of the leading health insurance names, and provides medical benefits through a range of integrated healthcare plans and related services, along with a wide range of specialty products such as life and disability insurance benefits, dental, vision, behavioral health benefit services, as well as long-term care insurance and flexible spending accounts.
---
A58 Company Deck
---
A58 Earnings Call
Q1 2024
0:00 / 0:00
---
A58 Stock 12 Months Forecast
Average Price Target
€566.06
▲(12.36% Upside)
Technical Analysis
Best Analysts Covering A58
1 Year
1 Year Success Rate
12/14 ratings generated profit
1 Year Average Return
+8.52%
reiterated a buy rating 10 days ago
Copying Kevin Fischbeck's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +8.52% per trade.
---